On Friday, the United States extended the authorization of the reinforcements of the Covid-19 vaccine to all people over 18 years of age, six months after completing their primary vaccination series, health authorities announced.
The Food and Drug Administration (FDA) said that the emergency use authorization granted to laboratories Pfizer and Modern helped “provide ongoing protection against Covid-19, including against the serious consequences that can occur, such as hospitalization or death.”
The two drug companies had announced shortly before that they had obtained FDA approval.
This emergency use authorization comes at a critical time as we enter the winter months and face a growing number of Covid-19 cases and hospitalizations across the country, “said Moderna CEO Stephane Bancel.
People over 18 years of age who received the single-dose vaccine of Johnson & Johnson in the United States they were already entitled to a second dose, two months after their first injection.
In the case of those vaccinated with Pfizer and Modern, the third dose was reserved until now only for certain categories of people: those over 65, adults at risk of developing a severe form of the disease or those with high exposure to the virus, for example through their work .
This announcement comes at a time when cases are on the rise again in the United States, with an average of 85,000 new cases of Covid-19 every day (compared to about 70,000 at the end of October), and about 1,000 deaths a day.
Some states in the United States, including California, had already begun allowing booster doses for all adults, even before the recommendations of health agencies, in hopes of containing the spread of the epidemic before the holiday season. .
Reference-www.eleconomista.com.mx